Stay updated on Avelumab and Palbociclib in Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Avelumab and Palbociclib in Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avelumab and Palbociclib in Breast Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.3%
    Check dated 2025-04-30T13:55:55.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.4 to v2.15.0, indicating a revision in the content. The phrase 'Here’s how you know' has been modified, suggesting a change in the way information is presented.
    Difference
    1.0%
    Check dated 2025-04-16T02:03:57.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for March 11, 2025. However, there are no significant changes to core content, pricing, or availability.
    Difference
    0.7%
    Check dated 2025-04-08T22:45:18.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The clinical trial for Avelumab or Hydroxychloroquine with or without Palbociclib to eliminate dormant breast cancer (PALAVY) has been updated to a new date of March 11, 2025, replacing the previous date of March 12, 2024.
    Difference
    1.0%
    Check dated 2025-03-18T05:33:17.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-24T19:05:22.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    6%
    Check dated 2025-02-10T09:24:07.000Z thumbnail image

Stay in the know with updates to Avelumab and Palbociclib in Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avelumab and Palbociclib in Breast Cancer Clinical Trial page.